title: Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).
abstract: The pharmacologic treatment of allergic rhinitis proposed by ARIA is an evidence-based and step-wise approach based on the classification of the symptoms. The ARIA workshop, held in December 1999, published a report in 2001 and new information has subsequently been published. The initial ARIA document lacked some important information on several issues. This document updates the ARIA sections on the pharmacologic and anti-IgE treatments of allergic rhinitis. Literature published between January 2000 and December 2004 has been included. Only a few studies assessing nasal and non-nasal symptoms are presented as these will be discussed in a separate document.
authors.affiliation: University Hospital and INSERM U454, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.forename: P
authors.initials: P
authors.lastname: van Cauwenberge
authors.forename: N
authors.initials: N
authors.lastname: Aït Khaled
authors.forename: C
authors.initials: C
authors.lastname: Bachert
authors.forename: C E
authors.initials: CE
authors.lastname: Baena-Cagnani
authors.forename: J
authors.initials: J
authors.lastname: Bouchard
authors.forename: C
authors.initials: C
authors.lastname: Bunnag
authors.forename: G W
authors.initials: GW
authors.lastname: Canonica
authors.forename: K-H
authors.initials: KH
authors.lastname: Carlsen
authors.forename: Y-Z
authors.initials: YZ
authors.lastname: Chen
authors.forename: A A
authors.initials: AA
authors.lastname: Cruz
authors.forename: A
authors.initials: A
authors.lastname: Custovic
authors.forename: P
authors.initials: P
authors.lastname: Demoly
authors.forename: R
authors.initials: R
authors.lastname: Dubakiene
authors.forename: S
authors.initials: S
authors.lastname: Durham
authors.forename: W
authors.initials: W
authors.lastname: Fokkens
authors.forename: P
authors.initials: P
authors.lastname: Howarth
authors.forename: J
authors.initials: J
authors.lastname: Kemp
authors.forename: M L
authors.initials: ML
authors.lastname: Kowalski
authors.forename: V
authors.initials: V
authors.lastname: Kvedariene
authors.forename: B
authors.initials: B
authors.lastname: Lipworth
authors.forename: R
authors.initials: R
authors.lastname: Lockey
authors.forename: V
authors.initials: V
authors.lastname: Lund
authors.forename: S
authors.initials: S
authors.lastname: Mavale-Manuel
authors.forename: E O
authors.initials: EO
authors.lastname: Meltzer
authors.forename: J
authors.initials: J
authors.lastname: Mullol
authors.forename: R
authors.initials: R
authors.lastname: Naclerio
authors.forename: K
authors.initials: K
authors.lastname: Nekam
authors.forename: K
authors.initials: K
authors.lastname: Ohta
authors.forename: N
authors.initials: N
authors.lastname: Papadopoulos
authors.forename: G
authors.initials: G
authors.lastname: Passalacqua
authors.forename: R
authors.initials: R
authors.lastname: Pawankar
authors.forename: T
authors.initials: T
authors.lastname: Popov
authors.forename: P
authors.initials: P
authors.lastname: Potter
authors.forename: D
authors.initials: D
authors.lastname: Price
authors.forename: G
authors.initials: G
authors.lastname: Scadding
authors.forename: F E R
authors.initials: FE
authors.lastname: Simons
authors.forename: V
authors.initials: V
authors.lastname: Spicak
authors.forename: E
authors.initials: E
authors.lastname: Valovirta
authors.forename: D-Y
authors.initials: DY
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Yawn
authors.forename: O
authors.initials: O
authors.lastname: Yusuf
mesh_terms: D000818:Animals; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; C026408:anti-IgE antibodies; D007073:Immunoglobulin E